AACE Hands-On Diabetes Technologies and Skills Certificate

Starts: 6/23/2025 |  Expires: 6/23/2027

The program explores the current landscape of diabetes technology, including continuous glucose monitors (CGMs), insulin pumps, and connected insulin pens. Participants will learn about key features of these technologies and review a number of case studies illustrating how the products can enhance diabetes management.

To earn the full AACE Hands-On Diabetes Technologies and Skills Certificate, you must also attend the in-person hands-on skills workshop held at the AACE Annual Meeting and complete the post-test in AACE’s My Learning Center.

Image For Activity Cover
Availability
On-Demand
Cost
Member: $175.00
Non-Member: $295.00
Credit Offered
3 CME Credits
3 Nursing Credits
3 ABIM-MOC Points
  • Certificate Information
  • Accreditation Statements
  • Learning Objectives
  • Target Audience
  • Statement of Need
  • Disclosures and Conflicts of Interest
  • Recommended
What is this certificate program about?

This comprehensive online certificate program explores the current landscape of diabetes technology, including continuous glucose monitors (CGMs), insulin pumps, and connected insulin pens. Participants will learn about key features of these technologies and review a number of case studies illustrating how the products can enhance diabetes management.

Who is this certificate designed for?

The primary target audience includes Endocrinologists and Fellows. The secondary target audience includes Nurse Practitioners, Physician Assistants, and other clinicians who treat endocrine conditions.

What are the steps to earn the certificate?

1. Attend the in-person hands-on session at the AACE Annual Meeting.

2. Purchase and complete the online didactic course, which includes recorded lectures and a self-assessment exam.

3. Successfully complete all components to earn your official AACE Certificate of Proficiency.


Will I earn CME / MOC credit? 

Yes. Credit was awarded for your attendance at the in-person Hands-on Skills course at AACE's annal meeting. You will receive an additional 3 credits for completing the certificate course. 

Is the certificate recognized professionally?

Yes. The certificate represents a commitment to clinical excellence and skills development. It is issued by AACE, a trusted leader in endocrine education, and can be added to your CB, credentialing documents, and professional profiles.

Participants have two years to complete all requirements for the certificate.

Physician Credit
The American College of Endocrinology (ACE) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The American College of Endocrinology (ACE) designates enduring activity for a maximum of 3 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ABIM MOC
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 3 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Only those who receive a passing score will be eligible for MOC credit.

Please allow two weeks for MOC points to appear within your account on the ABIM website. Participation information will be shared. 

Nursing Credit

Provider approved by the California Board of Registered Nursing, Provider Number 17762, for 3 contact hours.

At the end of this activity, participants will be able to:

  • Identify diabetes technology options including CGM, insulin pump, and connected pen devices.
  • Interpret CGM and insulin pump reports.
  • Determine how to adjust medications and recommend behavior changes based on data from CGM and insulin pump reports.

The primary target audience includes Endocrinologists and Fellows.

The secondary target audience includes Nurse Practitioners, Physician Assistants, and Other Clinicians who treat endocrine conditions.

The field of diabetes management technologies is evolving rapidly, with new devices and software solutions being introduced frequently. AACE Hands-On Diabetes Technologies and Skills Certificate is designed to provide Endocrinologists and care team members with updates of technological advancements and continuous education on specialized training to stay at the forefront of diabetes care.

Disclosure and Conflicts of Interest Policy:

The American Association of Clinical Endocrinologists (AACE) remains strongly committed to providing the best available evidence-based clinical information to participants of this educational activity and requires an open disclosure of any potential conflict of interest identified by our faculty members. It is not the intent of AACE to eliminate all situations of potential conflict of interest, but rather to enable those who are working with AACE to recognize situations that may be subject to question by others. All disclosed conflicts of interest are reviewed by the CME Subcommittee to ensure that such situations are properly evaluated and, if necessary, resolved. AACE educational standards pertaining to conflict of interest are intended to maintain the professional autonomy of the clinical experts inherent in promoting a balanced presentation of science. Through our review process, all AACE accredited activities are ensured of independent, objective, scientifically balanced presentations of information. Disclosure of any or no relationships will be made available for all educational activities. 

Planner Disclosures:

Planner Name

Ineligible Company

Relevant Financial Relationship

Diana Isaacs, PhD (1) Abbott, Dexcom, Medtronic, Insulet, Lilly, Novo Nordisk, Cequr, Sanofi

(2) Lilly, Sanofi, Medtronic, Lifescan, Sequel
(1) Speakers Bureau (2) Advisory Board
Natalie Bellini, MD

(1) Abbott, Dexcom, Medtronic, Embecta, Sanofi

(2) Medtronic, Sanofi

(1) Speaker / Consultant (2) Advisory Board
Mihail Zilbermint, MD

(1) ROM Tech

(2) Dexcom, Inc

(1) Stock (2) Consultant
Viral Shah, MD

(1) Alexion, Novo Nordisk, Enable Biosciences, Dexcom

(2) Dexcom, Genomelink and Lumosfit

(1) Research funding (2) Consulting
Rifka Schulman-Rosenbaum, MD Sanofi Publication Support

All of the relevant financial relationships listed for these individuals have been mitigated. All other planners for this educational activity have no relevant financial relationships to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients.


Faculty Disclosures:

Planner Name

Ineligible Company

Relevant Financial Relationship

Diana Isaacs, PhD (1) Abbott; Dexcom; Medtronic; Insulet; Lilly; Novo Nordisk; Cequr; Sanofi

(2) Lilly; Sanofi; Medtronic; Lifescan, Sequel
(1) Speakers Bureau (2) Advisory Board
Natalie Bellini, MD

(1) Abbott; Dexcom; Medtronic; Embecta; Sanofi

(2) Medtronic; Sanofi

(1) Speaker / Consultant (2) Advisory Board
Mihail Zilbermint, MD

(1) ROM Tech

(2) Dexcom, Inc.

(1) Stock (2) Consultant
Viral Shah, MD

(1) Alexion; Novo Nordisk; Enable Biosciences; Dexcom

(2) Dexcom; Genomelink; Lumosfit

(1) Research funding (2) Consulting
Rifka Schulman-Rosenbaum, MD Sanofi Publication Support

All of the relevant financial relationships listed for these individuals have been mitigated. All other faculty for this educational activity have no relevant financial relationships to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. 

Reviewer Disclosures:

Reviewer Name  Ineligible Company  Relevant Financial Relationship
Anupam Kotwal, MD
 Interpace Diagnostica; Immunovant

Consultant
All of the relevant financial relationships listed for these individuals have been mitigated. All other planners for this educational activity have no relevant financial relationships to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
Powered By